Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Distillery Therapeutics

TLR7 inhibition for COPD

January 2, 2024 11:54 PM UTC

Inhibiting the pattern recognition receptor TLR7 could help treat cigarette smoke-induced COPD by preventing mast cell activation.

In a human microarray database, TLR7 mRNA was increased in the airway epithelial and lung parenchymal tissues of people with COPD compared with healthy individuals, including smokers without COPD. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

University of Newcastle

BCIQ Target Profiles

Toll-like receptor 7 (TLR7)